Table of Contents Table of Contents
Previous Page  682 860 Next Page
Information
Show Menu
Previous Page 682 860 Next Page
Page Background

1.51, 95% CI 1.03–2.21,

p

= 0.04; 0 pads/d OR 1.94, 95% CI

1.26–2.99,

p

= 0.003); interaction tests of approach with age

and nerve-sparing status were not significant. Patient age

and surgical approach were the strongest predictors of

urinary continence recovery in adequacy analyses (Supple-

mentary Tables 1 and 2). LOESS curves did not show a change

in 24-h pad weights (at any time point) with increasing case

experience (Supplementary Fig. 1–4).

On GEE analysis, the mean IPSS urinary function scores

were not significantly different between the two cohorts at

any measured time point following catheter removal

( Fig. 4 )

. Mean urinary bother scores were significantly

lower in the posterior versus anterior RARP arm

[24_TD$DIFF]

at

[25_TD$DIFF]

1 wk,

2 wk and 1 month

( Fig. 5

). The surgical approach was

independently associated with urinary bother but not

urinary function scores (Supplementary Tables 3 and 4).

3.4.

Secondary outcomes: perioperative complications and

margin rates

There were no intraoperative complications in either arm.

Incidence of any postoperative complication was 12% versus

18% in anterior versus posterior arms (

p

= 0.9; Supplemen-

tary Table 5), including lymphoceles requiring percutaneous

drainage (

n

= 4 in anterior and

n

= 5 in posterior). Overall

PSM rates were 13% for the anterior versus 25% for the

posterior approach (

p

= 0.1); the corresponding rates of

nonfocal ( 2 mm) margins were 8% and 12%, respectively

(

p

= 0.2). The probability of BCRFS was 0.91 (95% CI

[26_TD$DIFF]

0.83–

[27_TD$DIFF]

1.0)

for anterior versus 0.91 (

[28_TD$DIFF]

0.83–

[29_TD$DIFF]

0.99) for posterior RARP

(

p

= 0.5), with a hazard ratio of 0.78 (0.21–2.91).

4.

Discussion

Within the last decade, a number of technical modifications

have been suggested to improve urinary continence in

patients undergoing RARP

[8,22,23] .

Schuessler et al

[24]

were the first to describe the Retzius-sparing approach in a

series of nine patients undergoing laparoscopic RP. Addi-

tionally, large-scale studies by Prabhu et al

[6]

, Donovan

et al

[7]

, and Sanda et al

[3]

have already shown that the

highest rates of urinary incontinence are seen 2–6 mo after

surgery, which improve thereafter. With these consider-

ations in mind, we designed an RCT to assess the impact of

the posterior approach on improving short-term ( 3 mo)

urinary continence recovery in comparison with our

standard anterior RARP. This, to our knowledge, represents

the first level 1 evidence for the Retzius-sparing approach.

We noted that 71% of patients undergoing posterior

RARP were continent 1 wk after catheter removal (com-

pared with 48% with anterior approach), which increased to

83% (vs 67%) and 95% (vs 86%) at 1 and 3 mo, respectively.

Surgical approach (posterior vs anterior RARP), along with

patient age, was one of the strongest predictors of urinary

continence recovery. While urinary continence in anterior

approach patients was comparable with what we have

reported previously

[25]

, patients undergoing posterior

RARP demonstrated one of the highest observed rates of

urinary continence in a level 1 study

[8] ,

with a median time

to urinary continence recovery of 2 d postcatheter removal.

As such, our findings corroborate those of Galfano et al

[10]

and Lim et al

[26]

. However, these studies comprised highly

selected patients with no concurrent matched controls, and

were limited by subjective assessment of the number of

pads. Additionally, few prior reports quantified the effect of

the RP approach on continence outcomes using pad weights

[15,27]

. In our study, patients in the posterior RARP arm

consistently showed a median 24-h pad weight of 0 g at all

study time points, while 24-h pad weights in the control

arm decreased from 25 g at 1 wk to 5 and 0 g at 1 and 3 mo,

respectively

[5_TD$DIFF]

. While our study was not designed to provide a

mechanistic explanation for earlier continence recovery

[(Fig._4)TD$FIG]

Fig. 4 – Mean IPSS urinary function (UF) scores at 1

[6_TD$DIFF]

week

[7_TD$DIFF]

(wk

[8_TD$DIFF]

), 2 wk, 1

[9_TD$DIFF]

month

[10_TD$DIFF]

(mo

[11_TD$DIFF]

), and 3 mo (following catheter removal) in patients undergoing

anterior versus posterior robot-assisted radical prostatectomy (RARP). Numbers along

Y

-axis represent estimates derived from generalized estimating

equations. Error bars represent 95% confidence intervals. IPSS = International

[12_TD$DIFF]

Prostate Symptom Score.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 7 7 – 6 8 5

682